Smoking Cessation Treatment for Head and Neck Cancer Patients

Stopped early · Early Phase 1

Conditions studied: Smoking Cessation

In brief

This is a pilot research study examining the use of varenicline (Chantix) and the nicotine patch. The study is designed to find out whether one of these medications is more effective for smoking cessation with head and neck cancer patients. The study has three parts: 1) two intake sessions; 2) an 8-week treatment phase, and 3) a 3-month follow-up.

Key facts

Study ID

NCT00931021

Run by

Yale University

People needed

7

Starts

2009-07-01

Expected to finish

2012-12-01

Last updated by the study team

2013-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 18 or older
• smoking 10 or more cigarettes per day
• diagnosed with and completed an initial course of treatment for any type of head and neck cancer
• life expectancy of 12 months or more

You may not qualify if…

• history of allergic reactions to adhesives
• unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia
• females of childbearing potential who are pregnant, nursing, or not practicing effective contraception

Where it is running

• Yale University School of Medicine — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.